Nature Communications (Jan 2017)

Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy

  • Marshall W. Hogarth,
  • Peter J. Houweling,
  • Kristen C. Thomas,
  • Heather Gordish-Dressman,
  • Luca Bello,
  • Cooperative International Neuromuscular Research Group (CINRG),
  • Elena Pegoraro,
  • Eric P. Hoffman,
  • Stewart I. Head,
  • Kathryn N. North

DOI
https://doi.org/10.1038/ncomms14143
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 13

Abstract

Read online

Duchenne muscular dystrophy is a disease caused by a single gene, characterized by progressive muscle weakness, but is variable between patients partly due to interactions of other genes. Here, the authors show that a commonACTN3polymorphism can modify the clinical phenotype.